A Phase 4 interventional study of Clotrimazole in Candidiasis, Vulvovaginal, sponsored by Instituto Palacios. Completed at 1 site in Spain. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-25.
Sponsored by Instituto Palacios · Phase 4, Interventional, and Health services research
To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.
265 studies on the registry are indexed under Candidiasis; 20 are open to participants now.
This study's enrollment of 56 is below the median of 99 across 186 interventional studies indexed under Candidiasis.
Browse Candidiasis studies →Instituto Palacios is the lead sponsor of 8 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Clotrimazole 500 mg
Other: Clotrimazole
All patients receive standard antifungal treatment for this type of infections consisting Clotrimazole 500 Single dose (standard treatment).
Vaginal swab test
To verify diagnosis of vaginal candidiasis
Time frame: Baseline
Vaginal swab test
To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis
Time frame: month 2
Vaginal swab test
To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis
Time frame: month 3
Vaginal swab test
To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis, only those with a history of more than four episodes in a year
Time frame: month 6
This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto Palacios